MK-5823
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MK-5823, covering 2016-02-05 to 2016-02-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-5823 in Overweight or Obese Participants Who Are Healthy or Have Type 2 Diabetes Mellitus (MK-5823-002) [Phase 1]